Pfizer and Indivior announce workforce reductions as part of restructuring efforts aimed at boosting productivity. Both pharmaceutical firms focus on streamlining operations amid evolving market demands.
Drugmakers plan to urge the US government to pause drug price negotiations, Bloomberg News reports. The move comes amid growing industry concerns over pricing reforms and potential market impacts.